期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张素转换酶抑制剂联用安体舒通治疗高血压大鼠心脏醛固酮逃逸及其对心肌纤维化的影响 被引量：5

原文传递
导出
作者 李淑梅 吴平生 钟世顺 修建成 张永生 郭志刚 赖文岩 张远慧 刘伊丽
机构地区 第一军医大学南方医院心内科
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2001年第6期447-448,共2页 Chinese Journal of Geriatrics
基金 国家自然科学基金 (3 9870 812 3 9870 3 3 1) 广东省自然科学基金 (980 2 3 5 )资助
关键词 高血压 血管紧张素转换酶抑制剂 安体舒通 醛固酮 心肌纤维化 动物实验
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

  • 1Campbell DJ,Duncan AM,Kladis A,et al.Converting enzyme inhibition and its withdrawl in spontaneously hypertensive rats[].Journal of Cardiovascular Pharmacology.1995
  • 2Struthers AD.Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure[].Journal of Cardiac Failure.1996
  • 3Silvestre JS,Robert V,Heymes C.Myocardial production of aldosterone and corticosterone in the rat[].Journal of Biological Chemistry.1998
  • 4Robert V,Heymes C,Sebastien J.Angiotensin AT1 receptor subtype as a cardiac target of aldosterone role in aldosterone-salt-induced fibrosis[].Journal of Hypertension.1999
  • 5Otsuka S,Sugano M,Makino N,et al.Interaction of mRNAs for angiotensin Ⅱ type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats[].Journal of Hypertension.1998
  • 6Struthers AD.Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure[].British Journal of Clinical Pharmacology.1999

同被引文献59

  • 1陈斌,杜凤和,李帮清.螺内酯对扩张型心肌病心力衰竭患者某些体液因子的影响[J].中国循环杂志,2004,19(6):409-411. 被引量：4
  • 2Cicoira M,Zanolla L,Rossi A,et al.Failure of aldosterone suppression despite angiotensin-converting enzyme inhibitor(ACEI) administration in chronic heart failure is associated with ACE DD genotype[J].J Am Coll Cardiol,2001,37(7):1808-1812.
  • 3The RALES Investigators.Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe congestive heart failure (the randomized aldactone evaluation study RALES)[J].Am J Cardiol,1996,78(8):902-907.
  • 4Blacher J,Amah G,Girerd X,et al.Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension[J].Am J Hypertens,1997,10(12 pt 1):1326-1334.
  • 5Clrata H,Hoffmann S,Ganten D.Tissue angiotensin II system in the human heart[J].Eur Heart J,1994,15:68-78.
  • 6Steassen J,Lijnen P,Fagard LJ,et al.Rise in plasma concentration of aldosterone during long-term angiotension II suppression[J].J Endocrinol,1981,91:457.
  • 7Dzau VJ,Hirsch A.Emerging role of tissue renin-angiotensin systems in congestive heart failure[J].Eur heart J,1990,11:65-71.
  • 8Urata H,Strobel F,Ganten D.Widespread tissue distribution of human chymase[J].J Hypertens,1994,12(suppl):S17-22.
  • 9Lee AF,Mac Fadyen RJ,Struthera AD.Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy; a longiyudinal study[J].Eur J Heart Fail,1999,1(4):401-406.
  • 10Richards M,Nicholls G.Aldosterone antagonism in heart failure[J].Lancet,1999,1354(9):789.

引证文献5

二级引证文献20

中华老年医学杂志
2001年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部